Christophe Desvignes

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne‐Bouhtou et al. · Neuropsychopharmacology · 2005 · 217 citations · Full text

Neurophysiology, Medicine, Glycine Transporter-1 Ssr504734 +12

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia☆

Denis Boulay, Philippe Pichat, Gihad Dargazanli et al. · Pharmacology Biochemistry and Behavior · 2008 · 87 citations

Molecular Pharmacology, Psychiatry, Glycine Transporter-1 +11

Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid

Christophe Desvignes, Lionel Bert, Laurent Vinet et al. · Neuroscience Letters · 1999 · 68 citations

Extracellular Striatal Dopamine, Neurophysiology, Medicine +12

First inter-laboratory study of a Supercritical Fluid Chromatography method for the determination of pharmaceutical impurities

Amandine Dispas, R.D. Marini, Vincent Desfontaine et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 60 citations · Full text

Inter-laboratory Study, Supercritical Fluid Chromatography, Supercritical Co2 +9

Effects of the β3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: Relevance to its antidepressant/anxiolytic-like profile

Y. Claustre, Maud Leonetti, Vincent Santucci et al. · Neuroscience · 2008 · 59 citations

Antidepressant/anxiolytic-like Profile, Agonist Sr58611a, Psychiatry +11